An Italian-based cell therapy business has just been bought by Evotec SE, a German therapeutics company.
Evotec just announced the strategic transaction to buy Rigenerand Srl, with the deal, signed in May 2022, now completed.
Based out of Medolla, Italy, the cell technology…
Source: www.labiotech.eu – Read more